Clinical Updates
Launch of Generic Butrans
The FDA has recently approved the generic equivalent of Butrans (Buprenorphine) transdermal patches. Butrans is…
Launch of Generic Strattera
The generic equivalent of Strattera (Atomoxetine) has just been released, following FDA approval. Strattera is…
Launch of Generic Vytorin
The generic equivalent of Vytorin (ezetimibe/simvastatin) has just been released, following FDA approval. Vytorin is…
Gabapentin to Become a Controlled Substance in Kentucky
Kentucky will become the first state to change gabapentin to a Schedule V controlled substance,…
Launch of Generic Pristiq
The generic equivalent of Pristiq (Desvenlafaxine) has just been released, following FDA approval. Pristiq is…
New Jersey Governor Signs Opioid Restriction Law
New Jersey Governor, Chris Christie, signed new legislation recently to help curb the opioid epidemic…
FDA Approves Vantrela ER
Vantrela ER (Hydrocodone Bitartrate) from Teva Pharmaceuticals has recently been granted approval from the FDA….
Generic Oxycontin ER — Temporarily Unavailable in Certain Strengths
The generic version of Oxycontin ER (oxycodone extended-release) is currently not available in the 10mg…
Launch of Generic EpiPen
The generic equivalent of EpiPen (epinephrine) is now available from Mylan. The EpiPen is used…
Launch of Generic Zetia
The FDA has recently approved the generic equivalent of Zetia (ezetimibe). Zetia is used to…
